DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631 Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally. 0

https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458 Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy. 0

https://www.zacks.com/stock/news/2227404/here-s-why-you-should-retain-insulet-podd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227404 Feb 16, 2024 - The huge success of Omnipod 5 boosts investors' confidence in Insulet (PODD). 0

https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054 Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance 0

https://www.zacks.com/stock/news/2226830/edwards-ew-gains-from-balanced-core-growth-and-new-launches?cid=CS-ZC-FT-analyst_blog|zer_report_update-2226830 Feb 15, 2024 - Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World. 0

https://www.zacks.com/stock/news/2226281/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2226281 Feb 14, 2024 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan. 0

https://www.zacks.com/stock/news/2223473/zimmer-biomet-zbh-q4-earnings-top-estimates-margins-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2223473 Feb 08, 2024 - Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter. 0

https://www.zacks.com/stock/news/2222702/cvs-health-cvs-q4-earnings-top-estimates-2024-eps-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2222702 Feb 07, 2024 - Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues. 0

https://seekingalpha.com/article/4666216-stryker-corporation-syk-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Jan 30, 2024 - Stryker Corporation (NYSE:NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ETCompany ParticipantsKevin Lobo – Chair and Chief Executive... 0

https://www.zacks.com/stock/news/2218369/stryker-syk-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218369 Jan 30, 2024 - The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0